Amicus Therapeutics
FOLD
#3324
Rank
โ‚ฌ3.78 B
Marketcap
12,06ย โ‚ฌ
Share price
0.14%
Change (1 day)
28.95%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): โ‚ฌ3.87 Million

According to Amicus Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ0.59 Billion. In 2024 the company made an earning of -โ‚ฌ24.26 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ3.87 M-115.98%
2024 -โ‚ฌ24.26 Million-80.84%
2023 -โ‚ฌ0.13 Billion-37.98%
2022 -โ‚ฌ0.21 Billion0.2%
2021 -โ‚ฌ0.21 Billion-11.92%
2020 -โ‚ฌ0.24 Billion-22.94%
2019 -โ‚ฌ0.31 Billion1.95%
2018 -โ‚ฌ0.3 Billion-22.27%
2017 -โ‚ฌ0.38 Billion120.39%
2016 -โ‚ฌ0.18 Billion54.24%
2015 -โ‚ฌ0.12 Billion88.63%
2014 -โ‚ฌ59.09 Million10.92%
2013 -โ‚ฌ53.27 Million21.36%
2012 -โ‚ฌ43.9 Million8.3%
2011 -โ‚ฌ40.53 Million-14.33%
2010 -โ‚ฌ47.31 Million753.76%
2009 -โ‚ฌ5.55 Million-83.31%
2008 -โ‚ฌ33.2 Million-4.4%
2007 -โ‚ฌ34.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ17.58 B 418,322.32%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
โ‚ฌ1.60 B 38,117.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ7.86 B 187,031.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ57.86 Million-1,476.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.15 Million-650.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.57 B 13,534.52%๐Ÿ‡บ๐Ÿ‡ธ USA